calcitriol and Lymphoma--Non-Hodgkin

calcitriol has been researched along with Lymphoma--Non-Hodgkin* in 2 studies

Other Studies

2 other study(ies) available for calcitriol and Lymphoma--Non-Hodgkin

ArticleYear
Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021, Volume: 32, Issue:12

    Hypercalcemia occurs in up to 30% of patients with malignancies and can be due to osteolysis by metastases, parathyroid hormone-related protein (PTHrP), excess 1,25-dihydroxyvitamin D (1,25(OH)

    Topics: Calcitriol; Calcium; Female; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Vitamin D

2021
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-20, Volume: 28, Issue:27

    Vitamin D insufficiency is common in the United States, with low levels linked in some studies to higher cancer incidence, including non-Hodgkin's lymphoma (NHL). Recent data also suggest that vitamin D insufficiency is related to inferior prognosis in some cancers, although there are no data for NHL.. We tested the hypothesis that circulating 25-hydroxyvitamin D [25(OH)D] levels are predictive of event-free survival (EFS) and overall survival (OS) in a prospective cohort of 983 newly diagnosed patients with NHL. 25(OH)D and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] levels were measured by liquid chromatography-tandem mass spectrometry.. Mean age at diagnosis was 62 years (range, 19 to 94 years); 44% of patients had insufficient 25(OH)D levels (< 25 ng/mL) within 120 days of diagnosis. Median follow-up was 34.8 months; 404 events and 193 deaths (168 from lymphoma) occurred. After adjusting for known prognostic factors and treatment, 25(OH)D insufficient patients with diffuse large B-cell lymphoma (DLBCL) had inferior EFS (hazard ratio [HR], 1.41; 95% CI, 0.98 to 2.04) and OS (HR, 1.99; 95% CI, 1.27 to 3.13); 25(OH)D insufficient patients with T-cell lymphoma also had inferior EFS (HR, 1.94; 95% CI, 1.04 to 3.61) and OS (HR, 2.38; 95% CI, 1.04 to 5.41). There were no associations with EFS for the other NHL subtypes. Among patients with DLBCL and T-cell lymphoma, higher 1,25(OH)(2)D levels were associated with better EFS and OS, suggesting that any putative tumor 1-α-hydroxylase activity did not explain the 25(OH)D associations.. 25(OH)D insufficiency was associated with inferior EFS and OS in DLBCL and T-cell lymphoma. Whether normalizing vitamin D levels in these patients improves outcomes will require testing in future trials.

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Chromatography, Liquid; Disease-Free Survival; Female; Humans; Iowa; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Minnesota; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tandem Mass Spectrometry; Time Factors; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Young Adult

2010